CBK Stock Analysis: Commerzbank | XETRA
Banks - Regional | XETRA, Germany | Market Cap: 40.824m EUR | 12M Return: 43.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 104M
EPS Trend: 95.9%
Qual. Beats: 0
Rev. Trend: 36.9%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: under 40 is mostly noise, over 50 gets interesting, and over 70 is strong.
Commerzbank AG is a German universal bank that provides retail, commercial, and capital markets services through two segments: Private and Small-Business Customers, and Corporate Clients. Its operations span Germany, the rest of Europe, the Americas, and Asia, serving private individuals, SMEs, large corporates, financial service providers, and institutional clients.
The companys product range covers deposit accounts (current, money market, checking, and business accounts), credit and debit cards, insurance, pension products, and card payment terminals. Lending offerings include installment, renovation, car, and overdraft loans, plus real estate financing. On the capital markets side, Commerzbank trades securities such as shares, funds, ETFs, certificates, options, futures, and bonds, and also provides wealth management services. As a German regional bank within the global financials sector, it competes in a market historically dominated by Sparkassen and cooperative banks on the retail side and by larger universal banks in the corporate segment.
Commerzbank was founded in 1870 and is headquartered in Frankfurt am Main, Germany. It trades on the XETRA exchange under the ticker CBK.
- ECB rate cuts pressure net interest margins
- UniCredit stake buildup fuels merger speculation
- Polish mBank unit drives segment revenue growth
| Net Income: 2.70b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 12.13 > 1.0 |
| NWC/Revenue: -1.87k% < 20% (prev 357.2%; Δ -2.23k% < -1%) |
| CFO/TA 0.09 > 3% & CFO 51.8b > Net Income 2.70b |
| Net Debt (5.65b) to EBITDA (4.96b): 1.14 < 3 |
| Current Ratio: 0.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.13b) vs 12m ago -1.31% < -2% |
| Gross Margin: 58.67% > 18% (prev 50.36%; Δ 8.30% > 0.5%) |
| Asset Turnover: 3.51% > 50% (prev 4.39%; Δ -0.88% > 0%) |
| Interest Coverage Ratio: 0.37 > 6 (EBIT TTM 4.12b / Interest Expense TTM 11.1b) |
| A: -0.64 (Total Current Assets 65.5b - Total Current Liabilities 452b) / Total Assets 603b |
| B: 0.03 (Retained Earnings 19.7b / Total Assets 603b) |
| C: 0.01 (EBIT TTM 4.12b / Avg Total Assets 588b) |
| D: 0.05 (Book Value of Equity 30.6b / Total Liabilities 571b) |
| Altman-Z'' = -3.99 = D |
| DSRI: 2.01 (Receivables 350.0m/212.0m, Revenue 20.7b/25.2b) |
| GMI: 0.86 (GM 50.36% / 58.67%) |
| AQI: 1.10 (AQ_t 0.89 / AQ_t-1 0.81) |
| SGI: 0.82 (Revenue 20.7b / 25.2b) |
| TATA: -0.08 (NI 2.70b - CFO 51.8b) / TA 603b) |
| Beneish M = -2.40 (Cap -4..+1) = BBB |
As of July 02, 2026, the stock is trading at EUR 37.23 with a total of 1,622,906 shares traded. Over the past week, the price has changed by -0.64%, over one month by +0.43%, over three months by +18.71% and over the past year by +43.35%.
Current recommended Stop Loss: 35.10 (which is 5.7% or 2.2 ATR below the current price).
Commerzbank has no consensus analysts rating.
P/E Trailing = 17.1567
P/E Forward = 12.3762
P/S = 3.5202
P/B = 1.1921
P/EG = 0.9234
Revenue TTM = 20.7b EUR
EBIT TTM = 4.12b EUR
EBITDA TTM = 4.96b EUR
Long Term Debt = 71.1b EUR (from longTermDebt, last fiscal year)
Short Term Debt = unknown (none)
Debt = 71.1b EUR (corrected: LT Debt 71.1b + ST Debt none)
Net Debt = 5.65b EUR (calculated: Debt 71.1b - CCE 65.5b)
Enterprise Value = 46.5b EUR (40.8b + Debt 71.1b - CCE 65.5b)
Interest Coverage Ratio = 0.37 (Ebit TTM 4.12b / Interest Expense TTM 11.1b)
EV/FCF = 0.92x (Enterprise Value 46.5b / FCF TTM 50.6b)
FCF Yield = 108.9% (FCF TTM 50.6b / Enterprise Value 46.5b)
FCF Margin = 245.0% (FCF TTM 50.6b / Revenue TTM 20.7b)
Net Margin = 13.09% (Net Income TTM 2.70b / Revenue TTM 20.7b)
Gross Margin = 58.67% ((Revenue TTM 20.7b - Cost of Revenue TTM 8.54b) / Revenue TTM)
Gross Margin QoQ = 54.74% (prev 93.24%)
Tobins Q-Ratio = 0.08 (Enterprise Value 46.5b / Total Assets 603b)
Interest Expense / Debt = 15.58% (Interest Expense 11.1b / Debt 71.1b)
Taxrate = 28.07% (1.16b / 4.12b)
NOPAT = 2.96b (EBIT 4.12b * (1 - 28.07%))
Current Ratio = 0.14 (Total Current Assets 65.5b / Total Current Liabilities 452b)
Debt / Equity = 2.33 (Debt 71.1b / totalStockholderEquity, last quarter 30.6b)
Debt / EBITDA = 1.14 (Net Debt 5.65b / EBITDA 4.96b)
Debt / FCF = 0.11 (Net Debt 5.65b / FCF TTM 50.6b)
Total Stockholder Equity = 32.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.46% (Net Income 2.70b / Total Assets 603b)
RoE = 8.41% (Net Income TTM 2.70b / Total Stockholder Equity 32.1b)
RoCE = 3.99% (EBIT 4.12b / Capital Employed (Equity 32.1b + L.T.Debt 71.1b))
RoIC = 0.51% (NOPAT 2.96b / Invested Capital 581b)
WACC = 9.99% (E(40.8b)/V(112b) * Re(7.87%) + D(71.1b)/V(112b) * Rd(15.58%) * (1-Tc(0.28)))
Discount Rate = 7.87% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.39 | Cagr: -4.15%
[DCF] Terminal Value 69.91% ; FCFF base≈50.6b ; Y1≈50.8b ; Y5≈53.9b
[DCF] Fair Price = 592.1 (EV 655b - Net Debt 5.65b = Equity 649b / Shares 1.10b; r=9.99% [WACC]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: 95.86 | EPS CAGR: 26.70% | SUE: 0.41 | # QB: 0
Revenue Correlation: 36.87 | Revenue CAGR: 4.98% | SUE: 0.64 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.80 | Chg30d=+2.03% | Revisions=-20% | Analysts=5
EPS current Year (2026-12-31): EPS=3.07 | Chg30d=+1.31% | Revisions=+60% | GrowthEPS=+11.0% | GrowthRev=+8.9%
EPS next Year (2027-12-31): EPS=3.76 | Chg30d=+0.63% | Revisions=+33% | GrowthEPS=+22.4% | GrowthRev=+7.4%
[Analyst] Revisions Ratio: +60%